Product Information
LITHIUM CARBONATE ER 300 MG TB is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2012 per EA under NDC 64980020505. Its NADAC has been published 525 times since Jun 8, 2016.
Strength
300 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
64980020505
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LITHIUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA204779On Market Since
3/23/2016
Pharmacological Classes
Price Statistics
The NADAC for LITHIUM CARBONATE ER 300 MG TB has been published 525 times since Jun 8, 2016, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2012 per EA |
|---|---|
| All-time high | $0.2271 (Nov 13, 2024) |
| All-time low | $0.1260 (Dec 21, 2022) |
| 52-week high | $0.2172 |
| 52-week low | $0.1991 |
| Median price | $0.1534 |
| Average price | $0.1625 |
| Largest weekly change | +33.8% (Jun 19, 2024) |
| Weeks tracked | 525 |
| Tracking since | Jun 8, 2016 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LITHIUM CARBONATE ER 300 MG TB?
The current National Average Drug Acquisition Cost (NADAC) for LITHIUM CARBONATE ER 300 MG TB, manufactured by Rising Pharma Holdings Inc., is $0.2012 per EA (NDC 64980020505), effective Jun 24, 2026.
How has the price of LITHIUM CARBONATE ER 300 MG TB changed over time?
Over the history we have for it, the NADAC for LITHIUM CARBONATE ER 300 MG TB has held within roughly two percent of its current level. It has been tracked across 525 weekly CMS publications since Jun 8, 2016.
What are the highest and lowest recorded NADAC prices for LITHIUM CARBONATE ER 300 MG TB?
Since Jun 8, 2016, the NADAC for LITHIUM CARBONATE ER 300 MG TB has ranged from a low of $0.1260 (Dec 21, 2022) to a high of $0.2271 (Nov 13, 2024), with a median of $0.1534 per EA.
Are there cheaper alternatives to LITHIUM CARBONATE ER 300 MG TB?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LITHIUM CARBONATE 300 MG CAP, is $0.0959 per EA — about 52% below LITHIUM CARBONATE ER 300 MG TB.
Who manufactures LITHIUM CARBONATE ER 300 MG TB?
LITHIUM CARBONATE ER 300 MG TB (NDC 64980020505) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification